Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM compared with placebo when administered to bilateral nasolabial fold wrinkles.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Brighton Medical Corporation
Beverly Hills, California, United States
Therapeutics Clinical Research
San Diego, California, United States
Gwinnett Clinical Research Center
Snellville, Georgia, United States
Dermatology San Antonio
San Antonio, Texas, United States
Charlottesville Medical Research
Charlottesville, Virginia, United States
Institute of Anti Aging Research
Virginia Beach, Virginia, United States
Start Date
November 1, 2006
Primary Completion Date
July 1, 2008
Completion Date
May 1, 2009
Last Updated
March 13, 2012
218
ACTUAL participants
Autologous Human Fibroblasts (azficel-T)
BIOLOGICAL
Placebo
BIOLOGICAL
Lead Sponsor
Castle Creek Biosciences, LLC.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions